VF
CUE icon

Virtu Financial’s Cue Biopharma CUE Stock Holding History

Virtu Financial’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,652
Closed -$11K – 1724
2026
Q1 		$11K Buy
+1,652
New +$15.4K ﹤0.01% 1454
2025
Q4 		– Sell
-503
Closed -$11K – 1777
2025
Q3 		$11K Sell
503
-186
-27% -$4.37K ﹤0.01% 1337
2025
Q2 		$14K Buy
+689
New +$14.7K ﹤0.01% 1287
2025
Q1 		– Sell
-561
Closed -$18K – 1481
2024
Q4 		$18K Buy
+561
New +$21.1K ﹤0.01% 1314
2023
Q3 		– Sell
-586
Closed -$64K – 1415
2023
Q2 		$64K Buy
+586
New +$68.9K ﹤0.01% 1103
2021
Q3 		– Sell
-830
Closed -$290K – 1589
2021
Q2 		$290K Buy
+830
New +$322K 0.03% 743
2018
Q2 		– Sell
-551
Closed -$232K – 2053
2018
Q1 		$232K Buy
+551
New +$251K 0.01% 1247

Other funds holding CUE

BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $635M AUM 28.07% 1-Year Est. Return
SC
Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
LPC
Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM

Virtu Financial's CUE Position: Q2 2026 in Review

Virtu Financial sold out of Cue Biopharma (CUE) in Q2 2026, closing a stake of 1,652 shares — an estimated $11K sold.

Virtu Financial first reported a position in CUE in Q1 2018 and held it in 7 quarters. The position peaked at $290K in Q2 2021. 49 funds tracked by Wall St. Rank hold CUE as of Q2 2026.

  • Virtu Financial reported no remaining Cue Biopharma position as of Q2 2026 after selling out during the quarter.
  • Virtu Financial sold 1,652 Cue Biopharma shares in Q2 2026, an estimated $11K.
  • Virtu Financial first reported a position in Cue Biopharma in Q1 2018 and held it in 7 quarters.
  • Virtu Financial's Cue Biopharma position peaked at $290K in Q2 2021.
  • 49 funds tracked by Wall St. Rank held Cue Biopharma as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.